-
breakthrough
Time of Update: 2022-09-10
Domestic ECMO treats patients (photo courtesy of the interviewee)Zhuang Jian, a professor at the School of Mechanical Engineering of Xi'an Jiaotong University, said that before the outbreak of the new crown pneumonia, the R&D team had basically completed the sample trial production of ECMO centrifugal pump equipment and a full range of consumables, and conducted large animal experiments on anticoagulant coatings .
-
Blue Sail Medical: 2.5 billion pieces of health protection nitrile gloves project has been put into production successfully
Time of Update: 2022-08-25
5 billion health protection (nitrile gloves) project" production line achieved a successful start-up on September 20 and was successfully put into production According to the announcement of Blue Sail Medical on the evening of September 21, the company's "third-phase annual output of 2.
-
The 4th Medical Industry Innovation and Development Conference TAP Invited Buyer Service Launched
Time of Update: 2022-05-07
MIDC2021 will set up 6 themed exhibition areas, covering biotechnology and pharmaceuticals, medical devices and services, epidemic prevention technology and materials, traditional Chinese medicine, hydrogen medical products, medical beauty technology and other popular areas, creating a biomedical technology innovation for the industry, strengthening industrial cooperation, A panoramic display platform to promote industrial upgrading .
-
Freshly baked
Time of Update: 2022-02-21
Inventory of evidence-based evidence for vedolizumab in Asian UC patients The VARSITY post hoc analysis presented at the 2021 European Congress of Crohn's and Colitis Organization (ECCO) included 45 patients with moderate-to-severe disease in Hong Kong, Taiwan, and South Korea In patients with active UC [5], at week 52, the clinical response rate (28.
-
This study eliminates concerns about hormone therapy increasing the risk of heart disease
Time of Update: 2021-10-21
The results of the study were published in the article "Effects of menopausal hormone therapy on cardiovascular disease and type 2 diabetes in postmenopausal middle-aged women: An analysis of the Korean National Health Insurance Service Database" .
-
Bulletin on September 27, 2021: Domestic nasal spray new crown vaccine is effective within 24 hours; China has supplied a total of 3.4 billion doses of new crown vaccine to the world
Time of Update: 2021-09-29
As of September 25, 2021, Beijing has reported a total of 40 million doses of new crown virus vaccines, reaching 40,023,400 doses, and a total of 20,387,100 inoculations, of which 19,751,400 have completed the entire vaccination .
-
Kelun will win the first imitation of 300 million large varieties
Time of Update: 2021-09-13
In 2020, the total terminal sales of Chinese public medical institutions and physical pharmacies in Chinese cities will exceed 300 million yuan .
In 2020, the total terminal sales of Chinese public medical institutions and physical pharmacies in Chinese cities will exceed 300 million yuan .
-
Guizhou's measures to promote the high-quality development of the pharmaceutical industry
Time of Update: 2021-08-27
Medical Network, August 18 News On August 13, Guizhou Provincial Food and Drug Administration issued a notice on "Several Measures to Promote the High-Quality Development of the Pharmaceutical Indust
-
WHO: Globally diagnosed new crowns may exceed 300 million in early 2022
Time of Update: 2021-08-26
WHO: Globally diagnosed new crowns may exceed 300 million in early 2022 WHO: Globally diagnosed new crowns may exceed 300 million in early 2022 WHO: Globally diagnosed new crowns may exceed 300 million in early 2022 China News Service, August 12, reported that on the 11th, the World Health Organization warned that if the current development trend continues, the total number of confirmed cases of new crown in the world will exceed 300 million in early 2022 .
-
The State Food and Drug Administration approves the listing of new drugs for the treatment of psoriasis
Time of Update: 2021-08-26
Apomilast can effectively control psoriasis for a long time, reduce the recurrence of the disease, relieve the inflammation of psoriasis from the mechanism, improve the comorbidity of psoriasis, and fully meet the treatment needs of patients with psoriasis .
-
"Children's Autoimmune Hemolytic Anemia Diagnosis and Treatment Guidelines (2021 Edition)" released
Time of Update: 2021-06-01
For warm-antibody AIHA, glucocorticoids usually take effect within 24 to 48 hours, and the treatment response rate is 50% to 80%, but it is easy to relapse when the dose is reduced too quickly or suddenly stopped.
-
Orsondor Biotechnology Innovation Center Unveiled
Time of Update: 2021-05-31
Relying on the platform technology advantages of the innovation center and regional industry collection resources, Orsondor plans to promote dozens of new products (including equipment and reagents) that meet the needs of China's local medical market in the next five years; at the same time, it plans to introduce talents, Increase local and international cooperation and other measures to further enhance the operational level in China, and accelerate the construction of a "research-production-sales integrated ecosystem" in the Chinese market.
-
4 keywords and 7 key issues, interpretation of health care "14th Five-Year Plan" period tasks
Time of Update: 2021-03-06
The preparation and implementation of five-year and medium- and long-term planning is an important way to govern the country, economic and social development, and is a major institutional arrangement
-
The "floor price" heart stent landed smoothly, just the beginning
Time of Update: 2021-02-11
Pharmaceutical Network February 5th, with the deepening of the reform of the medical and health system, in recent years more and more price-cutting drugs, and medical device supplies price reduction, but also just in the past month, a full landing, including the people are very concerned about the heart stent (also known as the coronary stent).
-
Ted Pharmaceuticals was awarded the honorary title of "Top Ten Public Interest Enterprises
Time of Update: 2021-01-31
At the same time, under the epidemic, as an important member of China's pharmaceutical industry, Beijing Ted Pharmaceutical Co., Ltd. the first time to respond positively to the war "epidemic", to protect the supply of drugs, all-round safety prevention and control, external emergency assistance line, carried out a series of continuous donations, a total of more than 4 million yuan, the company's safety prevention and control in place, all links run smoothly.
